ICAD iCAD, Inc. Company Cash Funds

ICAD (icadmed.com) - company brandmark

iCAD, Inc. (ICAD) minimizes capital expenditures by utilizing the cloud infrastructure of external providers. The SaaS model for oncology diagnostics allows the business to scale easily through clinic subscriptions. The company's free cash flow reflects current liquidity trends, with the value holding at 0.02. Revenue stability is ensured by a combination of software license sales and the supply of specialized medical equipment.

ICAD - iCAD Company Cash on Hand over the range 07/04/2022 - 08/02/2025

Analytical breakdowns and data insights for company iCAD, Inc. (ICAD)

- stock quotes and analyst forecast:
- market capitalization data:
Fundamental company analysis:iCAD Inc.
Brand item of iCAD Corp

This metric captures the volume of liquid assets, determining the company's ability to cover operating expenses without resorting to debt capital. By analyzing cash flow dynamics, an investor assesses the rate of spending or accumulation. The amount of cash and cash equivalents serves as a diagnostic for the business's financial autonomy. For iCAD, Inc. (ICAD), this reserve is critical when scaling SaaS subscriptions. Sufficient capital ensures the development of the ProFound AI AI platform and expansion into US oncology centers.

Analysis of competing companies

Company Cash Volume ONC|HALO - Company Cash Reserve|Revolution Medicines - Company Cash on Hand|Company Cash Volume Ascentage Pharma AAPG|CGON - Company Cash Funds|Company Total Cash Volume URGN|BCAX: Company Cash Volume|PSNL - Company Liquid Assets|ERAS (Erasca Inc) - Company Cash Volume|Company Cash Reserve Delcath Systems Inc DCTH|Company Cash Funds YmAbs (YMAB)|Company Liquid Assets Aura Bio|Company Cash Volume CADL (Candel Therapeutics Inc.)|accuray.com (ARAY) - Company Cash Reserve|SELLAS Life Sciences Group - Company Cash Volume|ACTU - Company Cash Volume|CTOR: Company Cash Volume|Company Cash Reserve TuHURA (HURA)|TARA (Protara Therapeutics Inc) - Company Cash Volume|Fate Therapeutics, Inc. (FATE) - Company Liquid Assets|Company Cash on Hand WHWK (Aadi Bioscience, Inc.)|Company Liquid Assets TScan Therapeutics, Inc.|Company Cash Volume CSBR (Champions Oncology Corp)|Company Total Cash Amount XBIT (XBiotech USA)|CVM - Company Cash Funds|Company Cash Balance OSTX (ostherapies.com)|Radiopharm Theranostics Ltd (RADX) - Company Cash Funds|ARTV: Company Total Cash Amount|ANL (adlainortye.com) - Company Cash Volume|VERU: Company Cash Balance|Company Cash on Hand TPST (Tempest Tx)|Company Cash on Hand Xilio XLO|Company Cash Volume RENB (Renovaro)|Company Cash Volume Mural Bio MURA|Kairos Pharma Ltd - Company Cash Volume|OnKure Therapeutics (OKUR) - Company Cash on Hand|GDTC: Company Cash Volume|Curis Inc. - Company Cash Balance|Company Cash Funds apollomicsinc.com|THAR: Company Cash Balance|Company Cash Funds Advanced Biomed Corp (ADVB)|GNPX (Genprex, Inc) - Company Cash Balance|Company Cash Volume CLDI (Calidi Biotherapeutics)|sunshinebiopharma.com (SBFM) - Company Cash Reserve|Xenetic Bio - Company Cash Volume|SLRX (Salarius Pharmaceuticals, Inc.) - Company Cash and Cash Equivalents|PPBT: Company Cash Volume|Company Cash on Hand American Oncology Network Inc|BGNE (beigene.com) - Company Cash Volume|Company Cash and Cash Equivalents CKPT (Checkpoint Therapeutics)|Company Cash on Hand ELEV (Elevation Oncology Inc.)|Company Cash on Hand Ikena IKNA|Company Cash Volume NTBL (notablelabs.com)|VIRX - Company Cash on Hand|MOR: Company Cash on Hand|NAYA - Company Cash Volume|Ascentage Pharma (AAPGV) - Company Cash Funds